Orphan Drug Summit 2025

Boston, MA 02134, United States | 16 July 2025 - 17 July 2025
Overview

Join us for the Orphan Drug Summit 2025, where top-level industry leaders will meet with innovators to explore the latest technologies and manufacturing know-how shaping the future of rare diseases in healthcare.

The healthcare industry is transforming therapeutics for rare diseases, focusing on improved delivery, stability, and bioavailability. Manufacturers must navigate complex regulations to develop drugs that meet strict safety standards, delivering solutions that are both effective and safe.

Don’t miss our presentation from Kevin Schaab, PhD on Integrated Early Development Platform for Rare Disease Therapies, taking place on Wednesday, July 16th at Noon. 

Discover breakthroughs in orphan drug development, share in the collective knowledge, and drive progress in treating rare diseases.

Location 
DoubleTree Suites
400 Soldiers Field Road
Boston, MA 02134, United States
 

If you are attending, lets plan to meet up to discuss your drug development needs.

Request
Location
DoubleTree Suites
400 Soldiers Field Road
Boston, MA 02134, United States

Meet our Expert

We look forward to meeting you in Boston.

Dr. Kevin Schaab

Senior Drug Development Consultant

Dr. Kevin Schaab has over 25 years of experience in helping develop innovative pharmaceutical therapies, with significant experien...

About Kevin

More insight from our experts:

Read More
Translational Pharmaceutics, Dr. Helen Baker, Dr. Vanessa Zann, Drug Development Consulting, Drug Product, Philadelphia, Miami Accelerating Drug Development with Translational Pharmaceutics®
Read More
Drug Product, Integrated Programs, Dr. Asma Patel, Rare Diseases, Orphan Drugs Accelerated pathways and CMC challenges in rare disease drug development
Read More
Thierry Van Nieuwenhove, Translational Pharmaceutics, Integrated Programs, Drug Product, Clinical Pharmacology Interview with Thierry Van Nieuwenhove: On Quotient Sciences' Growth and Role in Accelerating Drug Development
Read More